The role of complement in arterial hypertension and hypertensive end organ damage

被引:33
|
作者
Wenzel, Ulrich O. [1 ]
Kemper, Claudia [2 ,3 ]
Bode, Marlies [1 ]
机构
[1] Univ Hosp Hamburg Eppendorf, Dept Med 3, Martinistr 52, D-20246 Hamburg, Germany
[2] NHLBI, Complement & Inflammat Res Sect CIRS, NIH, Bldg 10, Bethesda, MD 20892 USA
[3] Univ Lubeck, Inst Syst Inflammat Res, Lubeck, Germany
关键词
arterial hypertension; atypical hemolytic uremic syndrome; C5aR1; C5aR2; C3aR; C3; C1q; malignantnephrosclerosis; II-INDUCED HYPERTENSION; L CTSL1 PROMOTER; T-CELL; CONCISE GUIDE; THROMBOTIC MICROANGIOPATHY; INTRACELLULAR COMPLEMENT; C5A RECEPTOR; RENAL INJURY; C3; INFLAMMATION;
D O I
10.1111/bph.15171
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Increasing evidence indicates that hypertension and hypertensive end organ damage are not only mediated by haemodynamic injury but that inflammation also plays an important role. The complement system protects the host from a hostile microbial environment and maintains tissue and cell integrity through the elimination of altered or dead cells. As an important effector arm of innate immunity, it plays also central roles in the regulation of adaptive immunity. Thus, complement activation may drive the pathology of hypertension through its effects on innate and adaptive immune responses, aside from direct effects on the vasculature. Recent experimental data strongly support a role for complement in all stages of arterial hypertension. The remarkably similar clinical and histopathological features of malignant nephrosclerosis and atypical haemolytic uraemic syndrome suggest also a role for complement in the development of malignant nephrosclerosis. Here, we review the role of complement in hypertension and hypertensive end organ damage.
引用
收藏
页码:2849 / 2862
页数:14
相关论文
共 50 条
  • [1] A pathogenic role of complement in arterial hypertension and hypertensive end organ damage
    Wenzel, Ulrich O.
    Bode, Marlies
    Koehl, Joerg
    Ehmke, Heimo
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2017, 312 (03): : H349 - H354
  • [2] COMPLEMENT IN HYPERTENSION AND TARGET ORGAN DAMAGE
    Ruan, Cheng-Chao
    Gao, Ping-Jin
    JOURNAL OF HYPERTENSION, 2018, 36 : E45 - E45
  • [3] Role of monocytes/macrophages in renin-angiotensin system-induced hypertension and end organ damage
    Barhoumi, Tlili
    Todryk, Stephen
    FRONTIERS IN PHYSIOLOGY, 2023, 14
  • [4] A new evidence of end-organ damage in the patients with arterial hypertension: Epistaxis?
    Celik, Turgay
    Iyisoy, Atila
    Yuksel, Uygar Cagdas
    Karahatay, Serdar
    Tan, Yalcin
    Isik, Ersoy
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 141 (01) : 105 - 107
  • [5] A salt-sensing kinase in T lymphocytes, SGK1, drives hypertension and hypertensive end-organ damage
    Norlander, Allison E.
    Saleh, Mohamed A.
    Pandey, Arvind K.
    Itani, Hana A.
    Wu, Jing
    Xiao, Liang
    Kang, Jooeun
    Dale, Bethany L.
    Goleva, Slavina B.
    Laroumanie, Fanny
    Du, Liping
    Harrison, David G.
    Madhur, Meena S.
    JCI INSIGHT, 2017, 2 (13)
  • [6] Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies
    Giacomo Tini
    Giuliano Tocci
    Allegra Battistoni
    Matteo Sarocchi
    Camilla Pietrantoni
    Domitilla Russo
    Beatrice Musumeci
    Carmine Savoia
    Massimo Volpe
    Paolo Spallarossa
    Current Heart Failure Reports, 2023, 20 : 56 - 62
  • [7] Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies
    Tini, Giacomo
    Tocci, Giuliano
    Battistoni, Allegra
    Sarocchi, Matteo
    Pietrantoni, Camilla
    Russo, Domitilla
    Musumeci, Beatrice
    Savoia, Carmine
    Volpe, Massimo
    Spallarossa, Paolo
    CURRENT HEART FAILURE REPORTS, 2023, 20 (01) : 56 - 62
  • [8] Role of the Immune System in Hypertensive Target Organ Damage
    Kvakan, Heda
    Luft, Friedrich C.
    Muller, Dominik N.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2009, 19 (07) : 242 - 246
  • [9] Target organ damage in patients with arterial hypertension
    Barenbrock, M
    Rahn, KH
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1999, 28 (06) : 208 - 213
  • [10] The role of chemokines in hypertension and consequent target organ damage
    Rudemiller, Nathan P.
    Crowley, Steven D.
    PHARMACOLOGICAL RESEARCH, 2017, 119 : 404 - 411